methyl N-((benzyloxy)carbonyl)-N-methyl-L-valyl-L-prolinate | 134816-23-2

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: methyl N-((benzyloxy)carbonyl)-N-methyl-L-valyl-L-prolinate
• 英文别名: Z-N-Me-(S)-Val-(S)-Pro-OCH3；Z-NMe-(S)-Val-(S)-Pro-OMe；Cbz-MeVal-Pro-OMe；Cbz-N(Me)Val-Pro-OMe；methyl (2S)-1-[(2S)-3-methyl-2-[methyl(phenylmethoxycarbonyl)amino]butanoyl]pyrrolidine-2-carboxylate
• CAS: 134816-23-2
• 化学式: C₂₀H₂₈N₂O₅
• 分子量: 376.453
• InChiKey: UUIBEDYBIDFMQL-IRXDYDNUSA-N

物化性质

• 沸点：
  511.6±50.0 °C(Predicted)
• 密度：
  1.176±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  27
• 可旋转键数：
  8
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.55
• 拓扑面积：
  76.2
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  methyl N-((benzyloxy)carbonyl)-N-methyl-L-valyl-L-prolinate 在 palladium on activated charcoal N-甲基吗啉 、 sodium hydroxide 、 氰基磷酸二乙酯 、 氢气 、 三甲基乙酰氯 、 三乙胺 作用下， 以 甲醇 、 乙醇 、 二氯甲烷 、 水 、 乙酸乙酯 为溶剂， 反应 71.0h， 生成 dolastatin 15
  参考文献：
  名称：

  The Dolastatins 20. A Convenient Synthetic Route to Dolastatin 15

  摘要：

  A segment synthetic strategy was utilized for obtaining the Dolabella auricularia (Indian Ocean sea hare) depsipeptide dolastatin 15. Reaction of protected (S)-Hiva-(S)-Phe 2c with isopropenyl chloroformate followed by Meldrum's ester, cyclization (2c --> 3a) of the product in toluene and finally methylation afforded the key (S)-dolapyrrolidine (Dpy) derivative 3b. Condensation of tripeptide 8 with the three unit Dpy segment 5b followed by deprotection and coupling (diethyl phosphorocyanidate) led to dolastatin 15 in 11% overall yield. The powerful and selective activity of dolastatin 15 against the U.S. National Cancer Institute's panel of human cell lines has been summarized.

  DOI：

  10.1016/s0040-4020(01)89562-4
• 作为产物：
  描述：

  N-苄氧羰基-N-甲基-L-缬氨酸 、 L-脯氨酸甲酯盐酸盐 生成 methyl N-((benzyloxy)carbonyl)-N-methyl-L-valyl-L-prolinate
  参考文献：
  名称：

  Dolastatin-15 derivatives in combination with taxanes

  摘要：

  本发明提供了一种用于治疗患者癌症的组合物和方法，其中公式I中定义的化合物与紫杉醇、紫杉醇衍生物或类似物结合使用，可以比单独使用这些化合物更有效地产生抗癌效果。

  公开号：

  US06103698A1

文献信息

• [EN] MALT1 INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DE MALT1 ET LEURS UTILISATIONS
  申请人：UNIV CORNELL

  公开号：WO2017040304A1

  公开（公告）日：2017-03-09

  Provided herein are compounds of Formula (I) and pharmaceutical compositions thereof, which may be useful as MALT1 inhibitors. Also provided are for the treatment of proliferative disorders (e.g., cancer (e.g., non-Hodgkin' s lymphoma, diffuse large B-cell lymphoma, MALT lymphoma), benign neoplasm, a disease associated with angiogenesis,an autoimmune disease, an inflammatory disease, an autoinflammatory disease) by administering a compound of Formula (I).

  本文提供了化合物的化学式(I)及其药物组合物，可用作MALT1抑制剂。还提供了通过给予化合物的化学式(I)来治疗增生性疾病（例如癌症（例如非霍奇金淋巴瘤、弥漫性大B细胞淋巴瘤、MALT淋巴瘤）、良性肿瘤、与血管生成有关的疾病、自身免疫疾病、炎症性疾病、自身炎症性疾病）的方法。
• Dolastatin-15 derivatives in combination with taxanes
  申请人：BASF Aktiengesellschaft

  公开号：US06103698A1

  公开（公告）日：2000-08-15

  The present invention provides compositions and methods for the treatment of cancer in a subject wherein compounds of Formula I as defined herein in combination with paclitaxel, taxotere or modified taxane or taxoid analogs provide enhanced anticancer effects over the effects achieved with the individual compounds.

  本发明提供了一种用于治疗患者癌症的组合物和方法，其中公式I中定义的化合物与紫杉醇、紫杉醇衍生物或类似物结合使用，可以比单独使用这些化合物更有效地产生抗癌效果。
• MALT1 inhibitors and uses thereof
  申请人：Cornell University

  公开号：US10711036B2

  公开（公告）日：2020-07-14

  Provided herein are compounds of Formula (I) and pharmaceutical compositions thereof, which may be useful as MALT1 inhibitors. Also provided are for the treatment of proliferative disorders (e.g., cancer (e.g., non-Hodgkin's lymphoma, diffuse large B-cell lymphoma, MALT lymphoma), benign neoplasm, a disease associated with angiogenesis, an autoimmune disease, an inflammatory disease, an autoinflammatory disease) by administering a compound of Formula (I).

  本文提供的式(I)化合物及其药物组合物可用作 MALT1 抑制剂。还提供了通过施用式（I）化合物治疗增殖性疾病（如癌症（如非霍奇金淋巴瘤、弥漫大 B 细胞淋巴瘤、MALT 淋巴瘤）、良性肿瘤、与血管生成相关的疾病、自身免疫性疾病、炎症性疾病、自身炎症性疾病）。
• Total Synthesis of Depsilairdin
  作者：Dale E. Ward、Sandip G. Pardeshi

  DOI：10.1021/jo1009239

  日期：2010.8.6

  The total synthesis of depsilairdin, a host-selective phytotoxin isolated from Leptosphaeria maculans (the causal agent of blackleg disease of oilseed Brassicas), has been achieved by N-terminal extension of a suitably protected derivative of the hitherto unknown amino acid (2S,3S,4R)-3,4-dihydroxy-3-methyl-proline (Dhmp) followed by esterification with lairdinol A. The latter esterification, complicated by the sterically hindered nature of the carboxyl group, was accomplished by a novel method involving reaction of the 1-hydroxybenzotriazole (HOBt) derived active ester with the bromomagnesium alkoxide of lairdinol A. Three depsilairdin analogues were also prepared by replacing the Dhmp residue with L-proline and cis- and trans-4-hydroxy-L-proline. Phytotoxicity assays showed that the analogues were nontoxic to both blackleg-susceptible (brown mustard) and -resistant (canola) plants, suggesting that the presence of the Dhmp residue in depsilairdin is important for its host-selective toxicity toward brown mustard.
• Pettit, George R.; Herald, Delbert L.; Singh, Sheo Bux, Journal of the American Chemical Society, 1991, vol. 113, # 17, p. 6692 - 6693
  作者：Pettit, George R.、Herald, Delbert L.、Singh, Sheo Bux、Thornton, Timothy J.、Mullaney, Jeffrey T.

  DOI：——

  日期：——